Blue Owl Capital (NYSE:OWL) Stock Price Expected to Rise, Piper Sandler Analyst Says

Blue Owl Capital (NYSE:OWL - Get Free Report) had its price target lifted by Piper Sandler from $22.50 to $23.50 in a research note issued on Wednesday,Benzinga reports. The firm currently has an "overweight" rating on the stock. Piper Sandler's target price would indicate a potential upside of 21.01% from the company's previous close.

Other research analysts also recently issued reports about the company. Barclays dropped their price target on Blue Owl Capital from $29.00 to $20.00 and set an "overweight" rating on the stock in a research note on Monday, April 7th. Citigroup reduced their price objective on shares of Blue Owl Capital from $30.00 to $23.00 and set a "buy" rating for the company in a report on Tuesday, April 8th. Keefe, Bruyette & Woods upgraded shares of Blue Owl Capital from a "market perform" rating to an "outperform" rating and upped their target price for the stock from $20.00 to $23.00 in a report on Tuesday, May 20th. JMP Securities dropped their price target on shares of Blue Owl Capital from $32.00 to $28.00 and set a "market outperform" rating on the stock in a research report on Tuesday, April 8th. Finally, Cfra Research raised Blue Owl Capital to a "moderate buy" rating in a report on Thursday, March 27th. Two investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $24.02.

Blue Owl Capital Trading Up 1.0%

OWL stock traded up $0.20 during mid-day trading on Wednesday, reaching $19.42. The company's stock had a trading volume of 6,210,775 shares, compared to its average volume of 6,894,536. Blue Owl Capital has a 12 month low of $14.55 and a 12 month high of $26.73. The business's 50 day moving average price is $18.83 and its 200 day moving average price is $20.71. The company has a market cap of $29.86 billion, a price-to-earnings ratio of 149.40, a price-to-earnings-growth ratio of 1.29 and a beta of 1.17.

Blue Owl Capital (NYSE:OWL - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.20 by ($0.03). The company had revenue of $620.19 million for the quarter, compared to analyst estimates of $636.44 million. Blue Owl Capital had a return on equity of 19.74% and a net margin of 3.73%. As a group, equities analysts expect that Blue Owl Capital will post 0.92 EPS for the current fiscal year.

Hedge Funds Weigh In On Blue Owl Capital

Institutional investors have recently modified their holdings of the business. Rakuten Securities Inc. bought a new position in Blue Owl Capital in the 4th quarter valued at $27,000. MassMutual Private Wealth & Trust FSB boosted its holdings in shares of Blue Owl Capital by 380.4% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,326 shares of the company's stock worth $27,000 after buying an additional 1,050 shares during the last quarter. Banque Transatlantique SA purchased a new position in shares of Blue Owl Capital in the 1st quarter worth about $31,000. SVB Wealth LLC bought a new position in Blue Owl Capital during the first quarter valued at about $38,000. Finally, Cullen Frost Bankers Inc. increased its holdings in Blue Owl Capital by 39.1% during the first quarter. Cullen Frost Bankers Inc. now owns 2,075 shares of the company's stock worth $42,000 after buying an additional 583 shares during the last quarter. 35.85% of the stock is owned by institutional investors.

About Blue Owl Capital

Blue Owl Capital Inc operates as an asset manager in the United States. The company offers permanent capital base solutions that enables it to offer holistic framework of capital solutions to middle market companies, large alternative asset managers, and corporate real estate owners and tenants. It also provides direct lending products that offer private credit products comprising diversified, technology, first lien, and opportunistic lending to middle-market companies; liquid credit; GP strategic capital products, which offers capital solutions, including GP minority stakes, GP debt financing, and professional sports minority stakes; and real estate products that focuses on acquiring triple net lease real estate by investment grade or creditworthy tenants.